Summary
To assess the benefit of further gold treatment of rheumatoid arthritis (RA) patients who had already received more than 6 g of this metal, 24 such patients were included in a double-blind trial. Besides this “gold group” comprising 11 patients who received gold (Auromyose®) in the same dosage schedule as before the study, the trial included a “placebo group” comprising 13 patients who received gold in a suspension diluted 1/100. In either group clinical, laboratory, and radiological data did not differ after 6 and 24 months in relation to the results at entry except for the serum gold concentrations, which were lower in the placebo group. We conclude that discontinuation of the treatment in RA patients who have received more than 6 g gold is not harmful to the patients for at least two years after withdrawal.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ellman, P., Lawrence, J.S., Thorold, G.P. Gold therapy in rheumatoid arthritis. Br Med J 1940, 2, 314–316.
Fraser, T.N. Gold treatment in rheumatoid arthritis. Ann Rheum Dis 1945, 4, 71–75.
Sigler, J.W., Bluhm, G.B., Duncan, H., Sharp, J.T., Ensign, D.C., McCrum, W.R. Gold salts in the treatment of rheumatoid arthritis: a doubleblind study. Ann Intern Med 1974, 80, 21–26.
Gottlieb, N.L. Gold compounds in the rheumatic diseases. Eds: Kelley, W.H., Harris, jr., E.D., Ruddy, S., Sledge, C.B. In: Textbook of Rheumatology, W.B. Saunders Company, Philadelphia 1981, 796–814.
Van de Stadt, R.J., Abbo-Tilstra, B. Gold binding to blood cells and serum proteins during chrysotherapy. Ann Rheum Dis 1980, 39, 31–36.
The Research-subcommittee of the Empire Rheumatism Council. Gold therapy in rheumatoid arthritis. Ann Rheum Dis 1960, 19, 95–119.
The Research-subcommittee of the Empire Rheumatism Council. Gold therapy in rheumatoid arthritis. Ann Rheum Dis 1961, 20, 315–334.
Mascarenhas, B.R., Granda, J.L., Freyberg, R.H. Gold metabolism in patients with rheumatoid arthritis treated with gold compounds-reinvestigated. Arthritis Rheum 1972, 15, 391–402.
Cats, A. A multicentre controlled trial of the effects of different dosage of gold therapy, followed by a maintenance dosage. Agents Actions 1976, 6, 355–363.
McCarty, D.J., Carrera, G.F. Treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquine. JAMA 1982, 248, 1718–1723.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Van Der Leeden, H., Dijkmans, B.A.C., Hermans, J. et al. A double-blind study on the effect of discontinuation of gold therapy in patients with rheumatoid arthritis. Clin Rheumatol 5, 56–61 (1986). https://doi.org/10.1007/BF02030968
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02030968